Sikiric, P., Seiwerth, S., Grabarevi, ., Petek, M., Ruman, R., Turkovi, B., Rotkvi, I., Jagi, V., Duvnjak, M., Mie, S., Djai, S., eparovi, J., Veljaa, M., Sallmani, A., Banic, M., & Brki, T
In 2023, GLP-1 medications represented 6.9% of annual pharmacy claims for surveyed employers
For example, Wegovy prescribing information states that it is used with a reduced-calorie diet and increased physical activity to help certain adults and adolescents reduce excess body weight and maintain long-term weight reduction
SASA analysis indicated that the solvent-accessible surface area of the GPX3Diosgenin complex ranged from 95 to 110 nm, with no significant change in structural exposure after binding ( Figure 9F )
Clinical Implications for Chronic Therapy As GLP-1 receptor agonists become a cornerstone of diabetes management, clinicians must adapt their monitoring strategies
The average starting weight for both groups was 232 lb